The global burden of neurological disorders: translating evidence into policy
Neurological disorders are the leading cause of disability and the second leading cause of death worldwide. In the past 30 years, the absolute numbers of deaths and people with disabilities owing to neurological diseases have risen substantially, particularly in low-income and middle-income countrie...
Gespeichert in:
| Veröffentlicht in: | Lancet neurology 2020-03, Vol.19 (3), p.255-265 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 265 |
|---|---|
| container_issue | 3 |
| container_start_page | 255 |
| container_title | Lancet neurology |
| container_volume | 19 |
| creator | Feigin, Valery L Vos, Theo Nichols, Emma Owolabi, Mayowa O Carroll, William M Dichgans, Martin Deuschl, Günther Parmar, Priya Brainin, Michael Murray, Christopher |
| description | Neurological disorders are the leading cause of disability and the second leading cause of death worldwide. In the past 30 years, the absolute numbers of deaths and people with disabilities owing to neurological diseases have risen substantially, particularly in low-income and middle-income countries, and further increases are expected globally as a result of population growth and ageing. This rise in absolute numbers of people affected suggests that advances in prevention and management of major neurological disorders are not sufficiently effective to counter global demographic changes. Urgent measures to reduce this burden are therefore needed. Because resources for health care and research are already overstretched, priorities need to be set to guide policy makers, governments, and funding organisations to develop and implement action plans for prevention, health care, and research to tackle the growing challenge of neurological disorders. |
| doi_str_mv | 10.1016/S1474-4422(19)30411-9 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9945815</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1474442219304119</els_id><sourcerecordid>2425648516</sourcerecordid><originalsourceid>FETCH-LOGICAL-c547t-bd8100e722f688e40f2448f8558d2c080644fc582922be569cb8cb8422c9729a3</originalsourceid><addsrcrecordid>eNqFUctKAzEUDaLY-vgEJeBGF6NJJpkmLhQpvqDiwroOM5nMNGWa1GSm0L83fVh0JQQS7j333JNzADjD6BojnN18YDqgCaWEXGJxlSKKcSL2QH9bztj-7k1IDxyFMEWIYMrxIeilmOOUM9QHb-OJhnXjiryBRedLbaGroNWdd42rjYrl0gQXGz7cwtbnNjR5a2wN9cJEtNLQ2NbBuWuMWp6Agypvgj7d3sfg8-lxPHxJRu_Pr8OHUaIYHbRJUXKMkB4QUmWca4oqQimvOGO8JApxlFFaKcaJIKTQLBOq4PHEjygxICJPj8HdhnfeFTNdKm2jskbOvZnlfildbuTfjjUTWbuFFIIyjlkkuNgSePfV6dDKqeu8jZoloYRllDOcRRTboJR3IXhd7TZgJFcpyHUKcmWxxEKuU5Aizp3_lreb-rE9Au43AB1NWhjtZVBmZWZpvFatLJ35Z8U35ymXfQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2425648516</pqid></control><display><type>article</type><title>The global burden of neurological disorders: translating evidence into policy</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>ProQuest Central UK/Ireland</source><creator>Feigin, Valery L ; Vos, Theo ; Nichols, Emma ; Owolabi, Mayowa O ; Carroll, William M ; Dichgans, Martin ; Deuschl, Günther ; Parmar, Priya ; Brainin, Michael ; Murray, Christopher</creator><creatorcontrib>Feigin, Valery L ; Vos, Theo ; Nichols, Emma ; Owolabi, Mayowa O ; Carroll, William M ; Dichgans, Martin ; Deuschl, Günther ; Parmar, Priya ; Brainin, Michael ; Murray, Christopher</creatorcontrib><description>Neurological disorders are the leading cause of disability and the second leading cause of death worldwide. In the past 30 years, the absolute numbers of deaths and people with disabilities owing to neurological diseases have risen substantially, particularly in low-income and middle-income countries, and further increases are expected globally as a result of population growth and ageing. This rise in absolute numbers of people affected suggests that advances in prevention and management of major neurological disorders are not sufficiently effective to counter global demographic changes. Urgent measures to reduce this burden are therefore needed. Because resources for health care and research are already overstretched, priorities need to be set to guide policy makers, governments, and funding organisations to develop and implement action plans for prevention, health care, and research to tackle the growing challenge of neurological disorders.</description><identifier>ISSN: 1474-4422</identifier><identifier>EISSN: 1474-4465</identifier><identifier>DOI: 10.1016/S1474-4422(19)30411-9</identifier><identifier>PMID: 31813850</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Age ; Aging ; Alzheimer's disease ; Dementia ; Demographics ; Disability ; Disease prevention ; Estimates ; Female ; Funding ; Global Burden of Disease - economics ; Global Burden of Disease - trends ; Global Health ; Health care ; Health care policy ; Humans ; Injuries ; Life Expectancy ; Low income groups ; Male ; Meningitis ; Metabolism ; Mortality ; Multiple sclerosis ; Nervous System Diseases - economics ; Nervous System Diseases - epidemiology ; Nervous System Diseases - mortality ; Neurological diseases ; Neurological disorders ; People with disabilities ; Population growth ; Quality of Life ; Quality-Adjusted Life Years ; Risk factors ; Sociodemographics ; Socioeconomic Factors ; Stroke</subject><ispartof>Lancet neurology, 2020-03, Vol.19 (3), p.255-265</ispartof><rights>2020 Elsevier Ltd</rights><rights>Copyright © 2020 Elsevier Ltd. All rights reserved.</rights><rights>2020. Elsevier Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c547t-bd8100e722f688e40f2448f8558d2c080644fc582922be569cb8cb8422c9729a3</citedby><cites>FETCH-LOGICAL-c547t-bd8100e722f688e40f2448f8558d2c080644fc582922be569cb8cb8422c9729a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2425648516?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>230,314,776,780,881,3536,27903,27904,64361,64365,65309,72215</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31813850$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Feigin, Valery L</creatorcontrib><creatorcontrib>Vos, Theo</creatorcontrib><creatorcontrib>Nichols, Emma</creatorcontrib><creatorcontrib>Owolabi, Mayowa O</creatorcontrib><creatorcontrib>Carroll, William M</creatorcontrib><creatorcontrib>Dichgans, Martin</creatorcontrib><creatorcontrib>Deuschl, Günther</creatorcontrib><creatorcontrib>Parmar, Priya</creatorcontrib><creatorcontrib>Brainin, Michael</creatorcontrib><creatorcontrib>Murray, Christopher</creatorcontrib><title>The global burden of neurological disorders: translating evidence into policy</title><title>Lancet neurology</title><addtitle>Lancet Neurol</addtitle><description>Neurological disorders are the leading cause of disability and the second leading cause of death worldwide. In the past 30 years, the absolute numbers of deaths and people with disabilities owing to neurological diseases have risen substantially, particularly in low-income and middle-income countries, and further increases are expected globally as a result of population growth and ageing. This rise in absolute numbers of people affected suggests that advances in prevention and management of major neurological disorders are not sufficiently effective to counter global demographic changes. Urgent measures to reduce this burden are therefore needed. Because resources for health care and research are already overstretched, priorities need to be set to guide policy makers, governments, and funding organisations to develop and implement action plans for prevention, health care, and research to tackle the growing challenge of neurological disorders.</description><subject>Age</subject><subject>Aging</subject><subject>Alzheimer's disease</subject><subject>Dementia</subject><subject>Demographics</subject><subject>Disability</subject><subject>Disease prevention</subject><subject>Estimates</subject><subject>Female</subject><subject>Funding</subject><subject>Global Burden of Disease - economics</subject><subject>Global Burden of Disease - trends</subject><subject>Global Health</subject><subject>Health care</subject><subject>Health care policy</subject><subject>Humans</subject><subject>Injuries</subject><subject>Life Expectancy</subject><subject>Low income groups</subject><subject>Male</subject><subject>Meningitis</subject><subject>Metabolism</subject><subject>Mortality</subject><subject>Multiple sclerosis</subject><subject>Nervous System Diseases - economics</subject><subject>Nervous System Diseases - epidemiology</subject><subject>Nervous System Diseases - mortality</subject><subject>Neurological diseases</subject><subject>Neurological disorders</subject><subject>People with disabilities</subject><subject>Population growth</subject><subject>Quality of Life</subject><subject>Quality-Adjusted Life Years</subject><subject>Risk factors</subject><subject>Sociodemographics</subject><subject>Socioeconomic Factors</subject><subject>Stroke</subject><issn>1474-4422</issn><issn>1474-4465</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqFUctKAzEUDaLY-vgEJeBGF6NJJpkmLhQpvqDiwroOM5nMNGWa1GSm0L83fVh0JQQS7j333JNzADjD6BojnN18YDqgCaWEXGJxlSKKcSL2QH9bztj-7k1IDxyFMEWIYMrxIeilmOOUM9QHb-OJhnXjiryBRedLbaGroNWdd42rjYrl0gQXGz7cwtbnNjR5a2wN9cJEtNLQ2NbBuWuMWp6Agypvgj7d3sfg8-lxPHxJRu_Pr8OHUaIYHbRJUXKMkB4QUmWca4oqQimvOGO8JApxlFFaKcaJIKTQLBOq4PHEjygxICJPj8HdhnfeFTNdKm2jskbOvZnlfildbuTfjjUTWbuFFIIyjlkkuNgSePfV6dDKqeu8jZoloYRllDOcRRTboJR3IXhd7TZgJFcpyHUKcmWxxEKuU5Aizp3_lreb-rE9Au43AB1NWhjtZVBmZWZpvFatLJ35Z8U35ymXfQ</recordid><startdate>20200301</startdate><enddate>20200301</enddate><creator>Feigin, Valery L</creator><creator>Vos, Theo</creator><creator>Nichols, Emma</creator><creator>Owolabi, Mayowa O</creator><creator>Carroll, William M</creator><creator>Dichgans, Martin</creator><creator>Deuschl, Günther</creator><creator>Parmar, Priya</creator><creator>Brainin, Michael</creator><creator>Murray, Christopher</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8C2</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>5PM</scope></search><sort><creationdate>20200301</creationdate><title>The global burden of neurological disorders: translating evidence into policy</title><author>Feigin, Valery L ; Vos, Theo ; Nichols, Emma ; Owolabi, Mayowa O ; Carroll, William M ; Dichgans, Martin ; Deuschl, Günther ; Parmar, Priya ; Brainin, Michael ; Murray, Christopher</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c547t-bd8100e722f688e40f2448f8558d2c080644fc582922be569cb8cb8422c9729a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Age</topic><topic>Aging</topic><topic>Alzheimer's disease</topic><topic>Dementia</topic><topic>Demographics</topic><topic>Disability</topic><topic>Disease prevention</topic><topic>Estimates</topic><topic>Female</topic><topic>Funding</topic><topic>Global Burden of Disease - economics</topic><topic>Global Burden of Disease - trends</topic><topic>Global Health</topic><topic>Health care</topic><topic>Health care policy</topic><topic>Humans</topic><topic>Injuries</topic><topic>Life Expectancy</topic><topic>Low income groups</topic><topic>Male</topic><topic>Meningitis</topic><topic>Metabolism</topic><topic>Mortality</topic><topic>Multiple sclerosis</topic><topic>Nervous System Diseases - economics</topic><topic>Nervous System Diseases - epidemiology</topic><topic>Nervous System Diseases - mortality</topic><topic>Neurological diseases</topic><topic>Neurological disorders</topic><topic>People with disabilities</topic><topic>Population growth</topic><topic>Quality of Life</topic><topic>Quality-Adjusted Life Years</topic><topic>Risk factors</topic><topic>Sociodemographics</topic><topic>Socioeconomic Factors</topic><topic>Stroke</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Feigin, Valery L</creatorcontrib><creatorcontrib>Vos, Theo</creatorcontrib><creatorcontrib>Nichols, Emma</creatorcontrib><creatorcontrib>Owolabi, Mayowa O</creatorcontrib><creatorcontrib>Carroll, William M</creatorcontrib><creatorcontrib>Dichgans, Martin</creatorcontrib><creatorcontrib>Deuschl, Günther</creatorcontrib><creatorcontrib>Parmar, Priya</creatorcontrib><creatorcontrib>Brainin, Michael</creatorcontrib><creatorcontrib>Murray, Christopher</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>Proquest Nursing & Allied Health Source</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Lancet Titles</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Lancet neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Feigin, Valery L</au><au>Vos, Theo</au><au>Nichols, Emma</au><au>Owolabi, Mayowa O</au><au>Carroll, William M</au><au>Dichgans, Martin</au><au>Deuschl, Günther</au><au>Parmar, Priya</au><au>Brainin, Michael</au><au>Murray, Christopher</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The global burden of neurological disorders: translating evidence into policy</atitle><jtitle>Lancet neurology</jtitle><addtitle>Lancet Neurol</addtitle><date>2020-03-01</date><risdate>2020</risdate><volume>19</volume><issue>3</issue><spage>255</spage><epage>265</epage><pages>255-265</pages><issn>1474-4422</issn><eissn>1474-4465</eissn><abstract>Neurological disorders are the leading cause of disability and the second leading cause of death worldwide. In the past 30 years, the absolute numbers of deaths and people with disabilities owing to neurological diseases have risen substantially, particularly in low-income and middle-income countries, and further increases are expected globally as a result of population growth and ageing. This rise in absolute numbers of people affected suggests that advances in prevention and management of major neurological disorders are not sufficiently effective to counter global demographic changes. Urgent measures to reduce this burden are therefore needed. Because resources for health care and research are already overstretched, priorities need to be set to guide policy makers, governments, and funding organisations to develop and implement action plans for prevention, health care, and research to tackle the growing challenge of neurological disorders.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>31813850</pmid><doi>10.1016/S1474-4422(19)30411-9</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1474-4422 |
| ispartof | Lancet neurology, 2020-03, Vol.19 (3), p.255-265 |
| issn | 1474-4422 1474-4465 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9945815 |
| source | MEDLINE; Elsevier ScienceDirect Journals; ProQuest Central UK/Ireland |
| subjects | Age Aging Alzheimer's disease Dementia Demographics Disability Disease prevention Estimates Female Funding Global Burden of Disease - economics Global Burden of Disease - trends Global Health Health care Health care policy Humans Injuries Life Expectancy Low income groups Male Meningitis Metabolism Mortality Multiple sclerosis Nervous System Diseases - economics Nervous System Diseases - epidemiology Nervous System Diseases - mortality Neurological diseases Neurological disorders People with disabilities Population growth Quality of Life Quality-Adjusted Life Years Risk factors Sociodemographics Socioeconomic Factors Stroke |
| title | The global burden of neurological disorders: translating evidence into policy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T01%3A38%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20global%20burden%20of%20neurological%20disorders:%20translating%20evidence%20into%20policy&rft.jtitle=Lancet%20neurology&rft.au=Feigin,%20Valery%20L&rft.date=2020-03-01&rft.volume=19&rft.issue=3&rft.spage=255&rft.epage=265&rft.pages=255-265&rft.issn=1474-4422&rft.eissn=1474-4465&rft_id=info:doi/10.1016/S1474-4422(19)30411-9&rft_dat=%3Cproquest_pubme%3E2425648516%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2425648516&rft_id=info:pmid/31813850&rft_els_id=S1474442219304119&rfr_iscdi=true |